Skip to menu Skip to content Skip to footer

2025

Journal Article

Clinical risk factors for hepatocellular carcinoma in Southeast Louisiana: a matched case–control study

Gonzalez, Gabrielle V., Danos, Denise M., Ferguson, Tekeda F., Therapondos, George, Hsieh, Mei-Chin and Leonardi, Claudia (2025). Clinical risk factors for hepatocellular carcinoma in Southeast Louisiana: a matched case–control study. Cancer Causes & Control, 1-9. doi: 10.1007/s10552-025-02021-3

Clinical risk factors for hepatocellular carcinoma in Southeast Louisiana: a matched case–control study

2025

Journal Article

776: GAPS AND DISPARITIES IN MONITORING AND ANTIVIRAL THERAPY AMONG PATIENTS WITH CHRONIC HEPATITIS C RECEIVING CARE AT U.S. SAFETY-NET HEALTH SYSTEMS

Wong, Robert, Jain, Mamta, Therapondos, George, Kshirsagar, Onkar and Thamer, Mae (2025). 776: GAPS AND DISPARITIES IN MONITORING AND ANTIVIRAL THERAPY AMONG PATIENTS WITH CHRONIC HEPATITIS C RECEIVING CARE AT U.S. SAFETY-NET HEALTH SYSTEMS. Gastroenterology, 169 (1), S-1648. doi: 10.1016/s0016-5085(25)04662-1

776: GAPS AND DISPARITIES IN MONITORING AND ANTIVIRAL THERAPY AMONG PATIENTS WITH CHRONIC HEPATITIS C RECEIVING CARE AT U.S. SAFETY-NET HEALTH SYSTEMS

2025

Journal Article

Su1657: SIGNIFICANT DECLINES IN ROUTINE HEPATOCELLULAR CARCINOMA SURVEILLANCE FOLLOWING PANDEMIC-RELATED DISRUPTIONS IN CARE AMONG ADULTS WITH CIRRHOSIS RECEIVING CARE AT U.S. SAFETY-NET HOSPITALS

Wong, Robert, Jones, Patricia D., Niu, Bolin, Pinheiro, Paulo, Thamer, Mae, Kshirsagar, Onkar, Zhang, Yi, Fass, Ronnie, Prieto-Bello, Daniela, Quirk, Lisa, Therapondos, George, Singal, Amit G. and Khalili, Mandana (2025). Su1657: SIGNIFICANT DECLINES IN ROUTINE HEPATOCELLULAR CARCINOMA SURVEILLANCE FOLLOWING PANDEMIC-RELATED DISRUPTIONS IN CARE AMONG ADULTS WITH CIRRHOSIS RECEIVING CARE AT U.S. SAFETY-NET HOSPITALS. Gastroenterology, 169 (1), S-1738. doi: 10.1016/s0016-5085(25)04864-4

Su1657: SIGNIFICANT DECLINES IN ROUTINE HEPATOCELLULAR CARCINOMA SURVEILLANCE FOLLOWING PANDEMIC-RELATED DISRUPTIONS IN CARE AMONG ADULTS WITH CIRRHOSIS RECEIVING CARE AT U.S. SAFETY-NET HOSPITALS

2025

Journal Article

The survival benefit of reabstinence after harmful alcohol use following early liver transplant for severe alcohol-associated hepatitis: a multicenter ACCELERATE study

Dukewich, Matthew, Dodge, Jennifer L., Lucey, Michael R., Rice, John P., Shetty, Kirti, Jakhete, Neha, Im, Gene Y., Weinberg, Ethan M., Hsu, Christine, Smith, Coleman, Ghobrial, R. Mark, Therapondos, George, Shoreibah, Mohamed, Aryan, Mahmoud, Eswaran, Sheila, Fix, Oren K., Maddur, Haripriya, Terrault, Norah and Lee, Brian P. (2025). The survival benefit of reabstinence after harmful alcohol use following early liver transplant for severe alcohol-associated hepatitis: a multicenter ACCELERATE study. The American Journal of Gastroenterology, 120 (4), 827-836. doi: 10.14309/ajg.0000000000002956

The survival benefit of reabstinence after harmful alcohol use following early liver transplant for severe alcohol-associated hepatitis: a multicenter ACCELERATE study

2025

Journal Article

A real-world experience with resmetirom: tolerability and access

Shuaibi, Sameera, Tobal, Ian, Gore, James, Ebiai, Ruona, Ozoral, Claire and Therapondos, George (2025). A real-world experience with resmetirom: tolerability and access. Gastro Hep Advances, 4 (9) 100709, 1-6. doi: 10.1016/j.gastha.2025.100709

A real-world experience with resmetirom: tolerability and access

2024

Journal Article

Sociodemographic disparities in hepatitis B treatment: a real-world analysis of 3 safety-net health systems in the United States

Wong, Robert J., Jain, Mamta K., Niu, Bolin, Therapondos, George, Kshirsagar, Onkar and Thamer, Mae (2024). Sociodemographic disparities in hepatitis B treatment: a real-world analysis of 3 safety-net health systems in the United States. Open Forum Infectious Diseases, 11 (10) ofae571. doi: 10.1093/ofid/ofae571

Sociodemographic disparities in hepatitis B treatment: a real-world analysis of 3 safety-net health systems in the United States

2024

Journal Article

Deploying a metabolic dysfunction-associated steatohepatitis consensus care pathway: findings from an educational pilot in three health systems

Kumar, Sonal, Mohanty, Arpan, Mantry, Parvez, Schwartz, Robert E., Haff, Madeleine, Therapondos, George, Noureddin, Mazen, Dieterich, Douglas, Girgrah, Nigel, Cohn, Kristi, Savanth, Mohanish and Fuchs, Michael (2024). Deploying a metabolic dysfunction-associated steatohepatitis consensus care pathway: findings from an educational pilot in three health systems. Bmc Primary Care, 25 (1) 265, 1-10. doi: 10.1186/s12875-024-02517-y

Deploying a metabolic dysfunction-associated steatohepatitis consensus care pathway: findings from an educational pilot in three health systems

2024

Journal Article

Clinician-level knowledge and barriers to hepatocellular carcinoma surveillance

Wong, Robert J., Jones, Patricia D., Niu, Bolin, Therapondos, George, Thamer, Mae, Kshirsagar, Onkar, Zhang, Yi, Pinheiro, Paulo, Kyalwazi, Beverly, Fass, Ronnie, Khalili, Mandana and Singal, Amit G. (2024). Clinician-level knowledge and barriers to hepatocellular carcinoma surveillance. JAMA Network Open, 7 (5) e2411076. doi: 10.1001/jamanetworkopen.2024.11076

Clinician-level knowledge and barriers to hepatocellular carcinoma surveillance

2024

Journal Article

Hepatitis delta virus testing and prevalence among chronic hepatitis B patients across three U.S. safety-net health systems

Wong, Robert J., Jain, Mamta K., Niu, Bolin, Zhang, Yi, Therapondos, George and Thamer, Mae (2024). Hepatitis delta virus testing and prevalence among chronic hepatitis B patients across three U.S. safety-net health systems. Clinical Gastroenterology and Hepatology. doi: 10.1016/j.cgh.2024.09.025

Hepatitis delta virus testing and prevalence among chronic hepatitis B patients across three U.S. safety-net health systems

2023

Journal Article

Responsiveness to vasoconstrictor therapy in hepatorenal syndrome type 1

Velez, Juan Carlos Q., Karakala, Nithin, Tayebi, Kasra, Wickman, Terrance J., Mohamed, Muner M. B., Kovacic, Rosemary A., Therapondos, George, Kanduri, Swetha R., Allegretti, Andrew S., Belcher, Justin M., Regner, Kevin R. and Wentowski, Cathy (2023). Responsiveness to vasoconstrictor therapy in hepatorenal syndrome type 1. Kidney360, 4 (4), E448-E456. doi: 10.34067/KID.0000000000000068

Responsiveness to vasoconstrictor therapy in hepatorenal syndrome type 1

2022

Journal Article

Artificial intelligence to identify harmful alcohol use after early liver transplant for alcohol-associated hepatitis

Lee, Brian P., Roth, Nitzan, Rao, Prathik, Im, Gene Y., Vogel, Alexander S., Hasbun, Johann, Roth, Yoel, Shenoy, Akhil, Arvelakis, Antonios, Ford, Laura, Dawe, Inga, Schiano, Thomas D., Davis, Jordan P., Rice, John P., Eswaran, Sheila, Weinberg, Ethan, Han, Hyosun, Hsu, Christine, Fix, Oren K., Maddur, Haripriya, Ghobrial, R. Mark, Therapondos, George, Dilkina, Bistra and Terrault, Norah A. (2022). Artificial intelligence to identify harmful alcohol use after early liver transplant for alcohol-associated hepatitis. American Journal of Transplantation, 22 (7), 1834-1841. doi: 10.1111/ajt.17059

Artificial intelligence to identify harmful alcohol use after early liver transplant for alcohol-associated hepatitis

2022

Journal Article

Low Rates of Hepatitis B Virus Treatment Among Treatment-Eligible Patients in Safety-Net Health Systems

Wong, Robert J., Jain, Mamta K., Therapondos, George, Niu, Bolin, Kshirsagar, Onkar and Thamer, Mae (2022). Low Rates of Hepatitis B Virus Treatment Among Treatment-Eligible Patients in Safety-Net Health Systems. Journal of Clinical Gastroenterology, 56 (4), 360-368. doi: 10.1097/MCG.0000000000001530

Low Rates of Hepatitis B Virus Treatment Among Treatment-Eligible Patients in Safety-Net Health Systems

2022

Journal Article

Patterns of alcohol use after early liver transplantation for alcoholic hepatitis

Lee, Brian P., Im, Gene Y., Rice, John P., Lazar, Ann, Weinberg, Ethan, Han, Hyosun, Maddur, Haripriya, Ghobrial, R. Mark, Therapondos, George, Hsu, Christine, Fix, Oren K., Eswaran, Sheila, Shetty, Kirti, Chhatwal, Jag, Dalgic, Ozden O., Jakhete, Neha, Mobley, Constance, Victor, David W., Mehta, Neil, Dinges, Lisanne, Rinella, Mary, Schiano, Thomas D., Lucey, Michael R. and Terrault, Norah (2022). Patterns of alcohol use after early liver transplantation for alcoholic hepatitis. Clinical Gastroenterology and Hepatology, 20 (2), 409-418. doi: 10.1016/j.cgh.2020.11.024

Patterns of alcohol use after early liver transplantation for alcoholic hepatitis

2021

Journal Article

Ultrasound stratification of hepatic steatosis using hepatorenal index

Johnson, Stephen I., Fort, Daniel, Shortt, Kenneth J., Therapondos, George, Galliano, Gretchen E., Nguyen, Theresa and Bluth, Edward I. (2021). Ultrasound stratification of hepatic steatosis using hepatorenal index. Diagnostics, 11 (8) 1443, 1-11. doi: 10.3390/diagnostics11081443

Ultrasound stratification of hepatic steatosis using hepatorenal index

2021

Journal Article

Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems

Wong, Robert J., Jain, Mamta K., Therapondos, George, Niu, Bolin, Kshirsagar, Onkar and Thamer, Mae (2021). Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems. American Journal of Gastroenterology, 116 (7), 1465-1475. doi: 10.14309/ajg.0000000000001195

Antiviral Therapy Reduces Risk of Cirrhosis in Noncirrhotic HBV Patients Among 4 Urban Safety-Net Health Systems

2021

Journal Article

Liver transplantation using hepatitis C virus-viremic donors into hepatitis C virus-aviremic recipients as standard of care

Bohorquez, Humberto, Bugeaud, Emily, Bzowej, Natalie, Scheuermann, Jennifer, Hand, Jonathan, Bruce, David, Carmody, Ian, Cohen, Ari, Joshi, Shobha, Seal, John, Sonnier, Dennis, Therapondos, George, Girgrah, Nigel, Anders, Stephanie and Loss, George E. (2021). Liver transplantation using hepatitis C virus-viremic donors into hepatitis C virus-aviremic recipients as standard of care. Liver Transplantation: official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society, 27 (4) lt.25925, 548-557. doi: 10.1002/lt.25925

Liver transplantation using hepatitis C virus-viremic donors into hepatitis C virus-aviremic recipients as standard of care

2020

Journal Article

The utilization and diagnostic yield of upper endoscopy for evaluation of gastrointestinal symptoms within the first year after liver transplantation

Daglilar, Ebubekir, Connolly, Sean E., Tahan, Veysel, Cohen, Ari and Therapondos, George (2020). The utilization and diagnostic yield of upper endoscopy for evaluation of gastrointestinal symptoms within the first year after liver transplantation. Cureus Journal of Medical Science, 12 (11) e11323. doi: 10.7759/cureus.11323

The utilization and diagnostic yield of upper endoscopy for evaluation of gastrointestinal symptoms within the first year after liver transplantation

2020

Journal Article

A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis

Harrison, Stephen A., Goodman, Zachary, Jabbar, Abdul, Vemulapalli, Ravi, Younes, Ziad H., Freilich, Bradley, Sheikh, Muhammad Y., Schattenberg, Jörn M., Kayali, Zeid, Zivony, Adam, Sheikh, Aasim, Garcia-Samaniego, Javier, Satapathy, Sanjaya K., Therapondos, George, Mena, Edward, Schuppan, Detlef, Robinson, James, Chan, Jean L., Hagerty, David T. and Sanyal, Arun J. (2020). A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis. Journal of Hepatology, 72 (5), 816-827. doi: 10.1016/j.jhep.2019.11.024

A randomized, placebo-controlled trial of emricasan in patients with NASH and F1-F3 fibrosis

2020

Journal Article

Sustained improvements in markers of liver disease severity after hepatitis C treatment

Wong, Robert J., Jain, Mamta K., Therapondos, George, Shiffman, Mitchell L., Kshirsagar, Onkar, Clark, Christopher and Thamer, Mae (2020). Sustained improvements in markers of liver disease severity after hepatitis C treatment. Journal of Clinical and Experimental Hepatology, 10 (2), 114-123. doi: 10.1016/j.jceh.2019.09.001

Sustained improvements in markers of liver disease severity after hepatitis C treatment

2020

Journal Article

Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis

Velez, Juan Carlos Q., Therapondos, George and Juncos, Luis A. (2020). Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis. Nature Reviews Nephrology, 16 (3), 137-155. doi: 10.1038/s41581-019-0218-4

Reappraising the spectrum of AKI and hepatorenal syndrome in patients with cirrhosis